80 Followers on Owler

Axsome

is a New York-based biopharmaceutical company that researches and develops novel therapies for the treatment of central nervous system disorders... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

Axsome

is a New York-based biopharmaceutical company that researches and develops novel therapies for the treatment of central nervous system disorders... Read more
Axsome CEO: Herriot Tabuteau

CEO

Herriot Tabuteau

CEO Approval Rating

90/100

2012

PublicNASDAQAXSM

Pharmaceuticals & Biotechnology
Biotechnology
2834 NAICS listing

Annual Revenue
$708.2M
Employees
380
Funding
$1.4B
Acquisitions
2

News

Conference Presentation
Feb 18, 2026
Benzinga
Axsome Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Product Launch
Feb 02, 2026
Yahoo
Axsome Therapeutics AXS-05 Alzheimer's Launch Could Drive Upside, RBC Says
Acquisition
Nov 07, 2025
GlobeNewswire
Axsome acquired Baergic Bio, Inc. for undisclosed amount
Funding
May 13, 2025
GlobalNewswire
Axsome received $570M in Post-IPO Debt Funding

Axsome Competitors

1Intra-Cellular
2Flexion
3Sage Therapeutics
4Voyager
5Neurona
6Transition Therapeutics
7Minerva Neurosciences
8FORUM Pharmaceuticals
9Rolfe Foundation
10Acorda
Unlock 12 + competitors

Trending Companies